Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 12, 2014, Pages 1353-1359

  Kwak, Dong Shin ^a   Jun, Dae Won ^a   Seo, Jae Gu ^b   Chung, Won Seok ^b   Park, Soon Eung ^b   Lee, Kang Nyeong ^a   Khalid Saeed, Waqar ^a   Lee, Hang Lak ^a   Lee, Oh Young ^a   Yoon, Byung Chul ^a   Choi, Ho Soon ^a  

^a Hanyang University   (South Korea)

^b Cellbiotech Co Ltd   (South Korea)

Author keywords

Chronic liver disease; Intestinal permeability; Probiotic; Small intestinal bacterial overgrowth

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEFECATION HABIT; DRUG EFFICACY; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LIVER FUNCTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT COURSE THERAPY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE; STREPTOCOCCUS THERMOPHILUS; FECES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; LIVER DISEASES, ALCOHOLIC; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PERMEABILITY; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; TIME; TREATMENT OUTCOME;

FECES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTESTINE, SMALL; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PERMEABILITY; PROBIOTICS; REPUBLIC OF KOREA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84927691380     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000214     Document Type: Article

References (24)

1. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130: S78-S90.
2. Lata J, Novotný I, Príbramská V, Juránková J, Fric P, Kroupa R, Stiburek O. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol 2007; 19:1111-1113.
3. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39:540-543.
4. Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 2011; 27:177-181.
5. Pinzone MR, Celesia BM, Di Rosa M, Cacopardo B, Nunnari G. Microbial translocation in chronic liver diseases. Int J Microbiol 2012; 2012:694629.
6. Deshpande A, Pasupuleti V, Thota P, Pant C, Mapara S, Hassan S, et al. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. J Gastroenterol Hepatol 2013; 28:235-242.
7. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98:2485-2490.
8. Bauer TM, Schwacha H, Steinbrückner B, Brinkmann FE, Ditzen AK, Aponte JJ, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97:2364-2370.
9. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11:483-490.
10. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51 (Suppl 1):1-22.
11. Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997; 42:738-742.
12. Rabiller A, Nunes H, Lebrec D, Tazi KA,Wartski M, Dulmet E, et al. Prevention of Gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002; 166:514-517.
13. Shindo K, Machida M, Miyakawa K, Fukumura M. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption. Am J Gastroenterol 1993; 88:2084-2091.
14. Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol 2005; 20:599-605.
15. Zhang SC, Wang W, Ren WY, He BM, Zhou K, Zhu WN. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis. World J Gastroenterol 2003; 9:534-538.
16. De Santis A, Famularo G, De Simone C. Probiotics for the hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 2000; 95:323-324.
17. Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A, et al. Intestinal permeability in patients with chronic liver diseases: its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 2010; 42:200-204.
18. Jun DW, Kim KT, Lee OY, Chae JD, Son BK, Kim SH, et al. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci 2010; 55:1465-1471.
19. Ilan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2609-2618.
20. Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 2012; 4:110-118.
21. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39:1441-1449.
22. Sabaté JM, Jouët P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008; 18:371-377.
23. Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010; 53:849-855.
24. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25:6-10.